| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | — | +408.6% |
| R&D Expense | $9.3M | — | +42.2% |
| SG&A Expense | $6.1M | — | +54.1% |
| Operating Income | -$10.5M | — | -9.5% |
| Income Tax | $0 | — | — |
| Net Income | -$127.5M | — | -372.8% |
| EPS (Basic) | -$11.65 | — | -56.8% |
| EPS (Diluted) | -$11.65 | — | -56.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.9M | +19.8% | +5.2% |
| Accounts Receivable | $5.0M | — | +134.7% |
| Current Assets | $113.9M | +24.5% | +7.5% |
| Total Assets | $120.7M | +22.3% | +5.1% |
| Current Liabilities | $9.6M | -3.7% | -9.6% |
| Total Liabilities | $398.9M | +39.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.5M | — | -34.7% |
| Capital Expenditures | $120K | — | +344.4% |
| Investing Cash Flow | -$120K | — | -344.4% |
| Financing Cash Flow | $30.3M | — | -60.4% |
| Free Cash Flow | -$12.6M | — | -35.6% |
| +265.4% |
| Stockholders' Equity | -$278.1M | -48.1% | -5002.1% |